• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

<











Wont happen. Rumors like this have happened numerous times with Stryker and Smith and Newphew. Not to mention it would be branching out in a big way from the current Stryker mix of products and the 2 cultures would simply not mix. Boston = Contract compliance, bullshit admin reports, call reports, micro managing. Stryker = here is your number, go sell shit and get paid.